Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder

NCT00484471 is registered in ClinicalTrials.gov with Korea Otsuka International Asia Arab as lead sponsor.

NCT NCT00484471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00484471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomized, Placebo Controlled Trial of Aripiprazole Plus Valproate in the Short-Term and Long-Term Treatment of Bipolar Disorder
Lead sponsor
Korea Otsuka International Asia Arab
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
November 30, 2012
Enrollment
127 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder